[go: up one dir, main page]

PE20080347A1 - CYPROFLOXACIN AND DEXAMETASONE OPHTHALMIC SOLUTION - Google Patents

CYPROFLOXACIN AND DEXAMETASONE OPHTHALMIC SOLUTION

Info

Publication number
PE20080347A1
PE20080347A1 PE2007000833A PE2007000833A PE20080347A1 PE 20080347 A1 PE20080347 A1 PE 20080347A1 PE 2007000833 A PE2007000833 A PE 2007000833A PE 2007000833 A PE2007000833 A PE 2007000833A PE 20080347 A1 PE20080347 A1 PE 20080347A1
Authority
PE
Peru
Prior art keywords
dexametasone
cyprofloxacin
ophthalmic solution
approximately
sodium
Prior art date
Application number
PE2007000833A
Other languages
Spanish (es)
Inventor
Hau Juan De Dios Quintana
Montano Jose Ruben Tornero
Duran Leopoldo Martin Baiza
Franco Norma Patricia Rodriguez
Jaime R Gonzalez
Original Assignee
Jimenez Bayardo Arturo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38845821&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080347(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jimenez Bayardo Arturo filed Critical Jimenez Bayardo Arturo
Publication of PE20080347A1 publication Critical patent/PE20080347A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA OFTALMICA EN SOLUCION PARA APLICACION TOPICA, QUE COMPRENDE: A) DEXAMETASONA MICRONIZADA APROXIMADAMENTE 0,1%; B) CLORHIDRATO DE CIPROFLOXACINO MONOHIDRATADO APROXIMADAMENTE AL 0,3%; C) CLORURO DE SODIO EN CANTIDAD SUFICIENTE PARA OBTENER 250-350mOsm/K; D) HIDROXIPROPILBETACICLODEXTRINAS AL 6%, SULFATO DE SODIO, EDETATO SODICO, CLORURO DE BENZALCONIO POLISORBATO 80 COMO SURFACTANTE NO IONICO. DICHA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE PADECIMIENTOS OCULARES CAUSADOS POR BACTERIAS Y HONGOSIT REFERS TO AN OPHTHALMIC PHARMACEUTICAL COMPOSITION IN SOLUTION FOR TOPICAL APPLICATION, WHICH INCLUDES: A) MICRONIZED DEXAMETASONE APPROXIMATELY 0.1%; B) CIPROFLOXACINE HYDROCHLORIDE MONOHYDRATED AT APPROXIMATELY 0.3%; C) SODIUM CHLORIDE IN A SUFFICIENT QUANTITY TO OBTAIN 250-350mOsm / K; D) 6% HYDROXYPROPILBETACICLODEXTRINS, SODIUM SULPHATE, SODIUM EDETATE, BENZALCONIUM CHLORIDE POLYYSORBATE 80 AS A NON-IONIC SURFACTANT. SAID COMPOSITION IS USEFUL FOR THE TREATMENT OF EYE DISEASES CAUSED BY BACTERIA AND FUNGI

PE2007000833A 2006-06-27 2007-06-27 CYPROFLOXACIN AND DEXAMETASONE OPHTHALMIC SOLUTION PE20080347A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2006/000062 WO2008002117A1 (en) 2006-06-27 2006-06-27 Ophthalmic solution of ciprofloxacin and dexamethasone

Publications (1)

Publication Number Publication Date
PE20080347A1 true PE20080347A1 (en) 2008-04-11

Family

ID=38845821

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000833A PE20080347A1 (en) 2006-06-27 2007-06-27 CYPROFLOXACIN AND DEXAMETASONE OPHTHALMIC SOLUTION

Country Status (3)

Country Link
CL (1) CL2007001894A1 (en)
PE (1) PE20080347A1 (en)
WO (1) WO2008002117A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107970244B (en) * 2016-10-21 2020-07-14 武汉武药科技有限公司 Composition containing ciprofloxacin and dexamethasone and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6740664B2 (en) * 1998-09-30 2004-05-25 Alcon, Inc. Methods for treating otic and ophthalmic infections
BR0115415A (en) * 2000-11-15 2003-09-09 Mohan A Chandavarkar Combination drug
WO2004069280A1 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent
WO2004087043A2 (en) * 2003-02-21 2004-10-14 Sun Pharmaceutical Industries Limited Stable ophthalmic formulation containing an antibiotic and a corticosteroid

Also Published As

Publication number Publication date
WO2008002117A1 (en) 2008-01-03
CL2007001894A1 (en) 2008-01-04

Similar Documents

Publication Publication Date Title
BR112014019667A2 (en) abeta antibody formulation
BR112012008518A2 (en) heterocyclic derivative and pharmaceutical composition
ME01456B (en) Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
PE20130009A1 (en) HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS
PE20141070A1 (en) STABLE POVIDONE IODINE COMPOSITIONS WITH STEROID OR NON-STEROID ANTI-INFLAMMATORY
EA200870216A1 (en) AMIDO COMPOUNDS AND THEIR APPLICATION AS MEDICINES
PE20121498A1 (en) NON-IRRITATING OPHTHALMIC COMPOSITIONS OF POVIDONE-IODINE
BRPI0518301A2 (en) insecticides
IN2012DN02465A (en)
NO20084853L (en) Compounds that are agonists of muscarinic receptors and which may be effective in the treatment of pain, Alzheimer's disease and / or schizophrenia
AU2012243329A8 (en) 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use
CL2008001839A1 (en) Compounds derived from 2,7-diazaspirocycles, inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1; pharmaceutical composition comprising said compounds; Useful to treat obesity, diabetes, glucose intolerance, type II diabetes, among other diseases.
CO6541569A2 (en) N1-PIRAZOLOESPIROCETONA ACETIL-COA CARBOXYLASE INHIBITORS
BR112013005438A2 (en) "A dry eye treatment agent characterized by combining the p2y2 receptor agonist and hyaluronic acid or a salt thereof, a method for the treatment of dry eye, and use of the p2y2 receptor agonist, and a hyaluronic acid or a salt of the same." same."
PE20081752A1 (en) NAPADISILATE SALT OF 5- (2 - {[6- (2,2-DIFLUORO-2-PHENYLETOXY) HEXYL] AMINO} -1-HYDROXYETHYL) -8-HYDROXYQUINOLIN-2- (1H) -ONE AS AN ADRENERGIC RECEPTOR AGONIST B2
PE20130217A1 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR PREPARATION
BR112013011580A2 (en) amino substituted bisphenyl pentanoic acid derivatives as nep inhibitors
PA8759501A1 (en) CRYSTAL FORMS
MX2010007295A (en) Stable aqueous cyclosporin compositions.
PE20080053A1 (en) OPHTHALMIC COMPOSITIONS OF ALCAFTADINE
PE20081751A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A MUSCARINE ANTAGONIST AND A BETA-2 ADRENORECEPTOR ANTAGONIST
PE20091392A1 (en) PHARMACEUTICAL COMPOSITIONS AS ANTI-INFLAMMATORY AGENTS
PE20120648A1 (en) 4-ISOPROPYLPHENYLGLUCITOL COMPOUNDS AS SGLT1 INHIBITORS
RU2012103538A (en) COMPOSITIONS AND METHODS FOR INHIBITING JAK PATHWAY
BR112013022094A2 (en) compositions and methods for non-surgical treatment of ptosis

Legal Events

Date Code Title Description
FX Voluntary withdrawal